DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Tregouet DA, Schnabel R, Alessi MC. et al; AtheroGene Investigators.
Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
J Thromb Haemost 2009;
7 (01) 49-57
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.